Rationale and Design of a Randomized, Double-Blind, Parallel-Group Study of Terutroban 30 mg/day versus Aspirin 100 mg/day in Stroke Patients: The Prevention of Cerebrovascular and Cardiovascular Events of Ischemic Origin with Terutroban in Patients with a History of Ischemic Stroke or Transient Ischemic Attack (PERFORM) Study
Keyword(s):
2010 ◽
Vol 24
(2)
◽
pp. 175-180
◽
Keyword(s):
Keyword(s):
2021 ◽
Keyword(s):